Literature DB >> 10702405

Lack of endothelial nitric oxide synthase aggravates murine accelerated anti-glomerular basement membrane glomerulonephritis.

P Heeringa1, H van Goor, Y Itoh-Lindstrom, N Maeda, R J Falk, K J Assmann, C G Kallenberg, J C Jennette.   

Abstract

Nitric oxide (NO) radicals generated by endothelial nitric oxide synthase (eNOS) are involved in the regulation of vascular tone. In addition, NO radicals derived from eNOS inhibit platelet aggregation and leukocyte adhesion to the endothelium and, thus, may have anti-inflammatory effects. To study the role of eNOS in renal inflammation, the development of accelerated anti-glomerular basement membrane (GBM) glomerulonephritis was examined in mice lacking a functional gene for eNOS and compared with wild-type (WT) C57BL/B6j mice. WT C57BL/6j mice (n = 12) and eNOS knockout (-/-) mice (n = 12) were immunized intraperitoneally with sheep IgG (0.2 mg in complete Freund's adjuvant). At day 6.5 after immunization, mice received a single i.v. injection of sheep anti-mouse GBM (1 mg in 200 microl PBS). Mice were sacrificed at day 1 and 10 after induction of the disease. All WT mice survived until day 10, whereas 1 eNOS-/- mouse died and 2 more became moribund, requiring sacrifice. At day 10, eNOS-/- mice had higher levels of blood urea nitrogen than WT mice (P < 0.02), although proteinuria was comparable. Immunofluorescence microscopy documented similar IgG deposition in both WT and eNOS-/- mice, but eNOS-/- mice had more extensive glomerular staining for fibrin at day 10 (P < 0.007). At day 10, light microscopy demonstrated that eNOS-/- mice had more severe glomerular thrombosis (P < 0.003) and influx of neutrophils (P < 0. 006), but similar degrees of overall glomerular endocapillary hypercellularity and crescent formation. In conclusion, accelerated anti-GBM glomerulonephritis is severely aggravated in eNOS-/- mice, especially with respect to glomerular capillary thrombosis and neutrophil infiltration. These results indicate that NO radicals generated by eNOS play a protective role during renal inflammation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10702405      PMCID: PMC1876860          DOI: 10.1016/S0002-9440(10)64957-7

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

1.  L-arginine depletion inhibits glomerular nitric oxide synthesis and exacerbates rat nephrotoxic nephritis.

Authors:  S Waddington; H T Cook; D Reaveley; A Jansen; V Cattell
Journal:  Kidney Int       Date:  1996-04       Impact factor: 10.612

2.  Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage.

Authors:  C Baylis; B Mitruka; A Deng
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

3.  Losartan-sensitive renal damage caused by chronic NOS inhibition does not involve increased renal angiotensin II concentrations.

Authors:  A M Verhagen; B Braam; P Boer; H J Gröne; H A Koomans; J A Joles
Journal:  Kidney Int       Date:  1999-07       Impact factor: 10.612

4.  Hypertension in mice lacking the gene for endothelial nitric oxide synthase.

Authors:  P L Huang; Z Huang; H Mashimo; K D Bloch; M A Moskowitz; J A Bevan; M C Fishman
Journal:  Nature       Date:  1995-09-21       Impact factor: 49.962

Review 5.  The nitric oxide pathway in glomerulonephritis.

Authors:  V Cattell; T Cook
Journal:  Curr Opin Nephrol Hypertens       Date:  1995-07       Impact factor: 2.894

6.  Exogenous nitric oxide prevents endotoxin-induced glomerular thrombosis in rats.

Authors:  G Westberg; P J Shultz; L Raij
Journal:  Kidney Int       Date:  1994-09       Impact factor: 10.612

7.  Aggravation of experimental glomerulonephritis by superimposed clip hypertension.

Authors:  J Neugarten; H D Feiner; R G Schacht; G R Gallo; D S Baldwin
Journal:  Kidney Int       Date:  1982-09       Impact factor: 10.612

8.  Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis.

Authors:  I Narita; W A Border; M Ketteler; N A Noble
Journal:  Lab Invest       Date:  1995-01       Impact factor: 5.662

9.  Consequences of acute nitric oxide synthesis inhibition in experimental glomerulonephritis.

Authors:  R Ferrario; K Takahashi; A Fogo; K F Badr; K A Munger
Journal:  J Am Soc Nephrol       Date:  1994-05       Impact factor: 10.121

10.  Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney.

Authors:  S Bachmann; H M Bosse; P Mundel
Journal:  Am J Physiol       Date:  1995-05
View more
  25 in total

Review 1.  Role of reactive oxygen and nitrogen species in the vascular responses to inflammation.

Authors:  Peter R Kvietys; D Neil Granger
Journal:  Free Radic Biol Med       Date:  2011-11-12       Impact factor: 7.376

2.  Lack of endothelial nitric-oxide synthase leads to progressive focal renal injury.

Authors:  Michael S Forbes; Barbara A Thornhill; Matthew H Park; Robert L Chevalier
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

3.  Endothelial nitric oxide synthase inhibits the development of autoimmune-mediated vasculitis in mice.

Authors:  Trenton R Schoeb; Tambi Jarmi; M John Hicks; Scott Henke; Abolfazl Zarjou; Hitoshi Suzuki; Philip Kramer; Jan Novak; Anupam Agarwal; Daniel C Bullard
Journal:  Arthritis Rheum       Date:  2012-12

4.  Blockade of the kinin B1 receptor ameloriates glomerulonephritis.

Authors:  Julie Klein; Julien Gonzalez; Stéphane Decramer; Flavio Bandin; Eric Neau; David J Salant; Peter Heeringa; Joao-Bosco Pesquero; Joost-Peter Schanstra; Jean-Loup Bascands
Journal:  J Am Soc Nephrol       Date:  2010-05-06       Impact factor: 10.121

5.  Endothelial von Willebrand factor release due to eNOS deficiency predisposes to thrombotic microangiopathy in mouse aging kidney.

Authors:  Takahiro Nakayama; Waichi Sato; Ashio Yoshimura; Li Zhang; Tomoki Kosugi; Martha Campbell-Thompson; Hideto Kojima; Byron P Croker; Takahiko Nakagawa
Journal:  Am J Pathol       Date:  2010-04-02       Impact factor: 4.307

6.  Nitric oxide production by glomerular podocytes.

Authors:  Oleg Palygin; Daria V Ilatovskaya; Vladislav Levchenko; Bradley T Endres; Aron M Geurts; Alexander Staruschenko
Journal:  Nitric Oxide       Date:  2017-11-08       Impact factor: 4.427

7.  Shift in Focus-To Explore the Role of the Endothelium in Kidney Disease.

Authors:  Ilse Daehn
Journal:  HSOA J Nephrol Ren Ther       Date:  2016-03-10

8.  Gene regulation in the vascular endothelium: why epigenetics is important for the kidney.

Authors:  Alisha Jamal; H S Jeffrey Man; Philip A Marsden
Journal:  Semin Nephrol       Date:  2012-03       Impact factor: 5.299

Review 9.  Refinement, reduction and replacement approaches to in vivo cardiovascular research.

Authors:  Michael Emerson
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

Review 10.  Nitric oxide regulation of protein trafficking in the cardiovascular system.

Authors:  Charles J Lowenstein
Journal:  Cardiovasc Res       Date:  2007-04-03       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.